Cargando…

Multistep pathogenesis of chronic myelomonocytic leukemia in patients

BACKGROUND: A multistep pathogenesis of myeloid leukemia including mutations in epigenetic, spliceosome, and signaling genes has been recently demonstrated in a preclinical model but is poorly validated in patients. METHODS: Clinical, phenotypic, and biologic features were compared between three dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geissler, Klaus, Jäger, Eva, Barna, Agnes, Gurbisz, Michael, Marschon, Renate, Graf, Temeida, Nösslinger, Thomas, Pfeilstöcker, Michael, Machherndl‐Spandl, Sigrid, Stauder, Reinhard, Zebisch, Armin, Sill, Heinz, Öhler, Leopold, Kusec, Rajko, Hoermann, Gregor, Valent, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310570/ https://www.ncbi.nlm.nih.gov/pubmed/35299281 http://dx.doi.org/10.1111/ejh.13768

Ejemplares similares

Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia
por: Geissler, Klaus, et al.
Publicado: (2020)

Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia
por: Machherndl‐Spandl, Sigrid, et al.
Publicado: (2021)

Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype
por: Heibl, Sonja, et al.
Publicado: (2020)

Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia—A Retrospective Analysis in 337 Patients
por: Geissler, Klaus, et al.
Publicado: (2020)

The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML): A representative and useful real-life data source for further biomedical research
por: Geissler, Klaus, et al.
Publicado: (2019)

Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival
por: Geissler, Klaus, et al.
Publicado: (2021)

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia
por: Huemer, Florian, et al.
Publicado: (2018)

Iron overload in myelodysplastic syndromes (MDS) – diagnosis, management, and response criteria: a proposal of the Austrian MDS platform
por: Valent, P, et al.
Publicado: (2008)

Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia
por: Geissler, Klaus, et al.
Publicado: (2019)

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
por: Pleyer, Lisa, et al.
Publicado: (2016)

Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents—A Prospective Cohort Study of the AGMT Study-Group
por: Leisch, Michael, et al.
Publicado: (2022)

Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors
por: Geissler, K, et al.
Publicado: (2016)

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group
por: Pleyer, Lisa, et al.
Publicado: (2017)

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group
por: Pleyer, Lisa, et al.
Publicado: (2014)

Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia
por: Berg, Johannes Lorenz, et al.
Publicado: (2021)

Phenotypic Characterization of Leukemia-Initiating Stem Cells in Chronic Myelomonocytic Leukemia
por: Eisenwort, Gregor, et al.
Publicado: (2021)

Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis
por: Caraffini, Veronica, et al.
Publicado: (2020)

Significance of hypergammaglobulinemia in patients with chronic myelomonocytic leukemia
por: Zack, Marie-Therese, et al.
Publicado: (2022)

TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer
por: Strassl, Irene, et al.
Publicado: (2023)

Significance of cardiovascular comorbidity in patients with chronic myelomonocytic leukemia
por: Lackner, David, et al.
Publicado: (2022)

Hospital outbreak caused by linezolid resistant Enterococcus faecium in Upper Austria
por: Kerschner, Heidrun, et al.
Publicado: (2019)

Significance of reduced renal function in patients with chronic myelomonocytic leukemia
por: Heschl, Julia, et al.
Publicado: (2022)

Significance of abnormal blood coagulation in patients with chronic myelomonocytic leukemia
por: Weinfurtner, Christoph, et al.
Publicado: (2022)

Significance of C-reactive protein in patients with chronic myelomonocytic leukemia
por: Liang-Fonseca, Jian, et al.
Publicado: (2022)

Evaluation of a multiplex ligation-dependent probe amplification assay for the detection of respiratory pathogens in oncological patients
por: Berning, Lucia, et al.
Publicado: (2014)

Bilaterale orbitale Affektion bei multiplem Myelom
por: Khalil, Baran, et al.
Publicado: (2023)

Is Myelodysplasia a Consequence of Normal Aging?
por: Heibl, Sonja, et al.
Publicado: (2021)

Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment Approaches
por: Geissler, Klaus
Publicado: (2021)

RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
por: Carr, Ryan M., et al.
Publicado: (2021)

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
por: Valent, Peter, et al.
Publicado: (2019)

Ruxolitinib withdrawal due to the COVID-19
por: Lucijanic, Marko, et al.
Publicado: (2021)

Treatment options and survival in real life during the past three decades in patients with chronic myelomonocytic leukemia
por: Reiser, Julia, et al.
Publicado: (2022)

Kinetics of multistep reactions
por: Helfferich, Friedrich G., 1922-2005
Publicado: (2004)

Multistep tumorigenesis and the microenvironment
por: Schedin, Pepper, et al.
Publicado: (2004)

PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE
por: Strassl, Irene, et al.
Publicado: (2023)

RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis
por: Zebisch, Armin, et al.
Publicado: (2019)

Multistep processes in nuclear reactions
por: Hodgson, P E
Publicado: (1995)

The rate limitation in multistep chambers
por: Breskin, Amos, et al.
Publicado: (1980)

Multistep nucleation of anisotropic molecules
por: Takahashi, Kazuaki Z., et al.
Publicado: (2021)

Genetic Landscape of Multistep Hepatocarcinogenesis
por: Takeda, Haruhiko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ve9luuu67ko9ahjq5qs4re1p29